Wellington Fernandes da Silva
Overview
Explore the profile of Wellington Fernandes da Silva including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oliveira J, Cano C, Junior J, Barreto G, Mendes F, de Melo R, et al.
Hematol Transfus Cell Ther
. 2025 Feb;
47(1):103741.
PMID: 39978056
Introduction: Bronchoscopy is frequently performed in the management of patients with acute leukemia due to their high susceptibility to infections. In this setting, it is performed in the context of...
2.
Lima K, Rojas C, Nogueira F, Silva W, Cavaglieri R, Nardinelli L, et al.
EJHaem
. 2024 Dec;
5(6):1366-1369.
PMID: 39691248
No abstract available.
3.
Lipreri da Silva J, Lima K, Ede B, Lazarini M, Vicari H, Nogueira F, et al.
Eur J Pharmacol
. 2024 Nov;
987:177161.
PMID: 39615869
Ezrin (EZR) is an actin-associated protein that is often upregulated in cancers. Here we investigate the role of EZR in acute lymphoblastic leukemia (ALL) and explore the therapeutic potential of...
4.
Lima K, Nogueira F, Cipelli M, Carvalho M, Pereira-Martins D, Silva W, et al.
Eur J Pharmacol
. 2024 Jun;
977:176723.
PMID: 38851560
Acute lymphoblastic leukemia (ALL), a complex malignancy, displays varying expression profiles of PIP4K2-related genes in adult patients. While PIP4K2A expression is elevated in ALL bone marrow cells compared to healthy...
5.
Castelo L, Silva W, Lincango M, Buccheri V, Perusini A, Arbelbide J, et al.
Clin Lymphoma Myeloma Leuk
. 2024 Mar;
24(6):407-411.
PMID: 38462425
No abstract available.
6.
Silva W, Mendes F, Melo R, Velloso E, Rocha V, Rego E
J Mycol Med
. 2023 Sep;
33(4):101434.
PMID: 37683564
Introduction: Invasive fungal infection (IFI) accounts for substantial morbidity during the treatment of acute myeloid leukemia (AML) in adults. Antifungal prophylaxis (AP) is needed during intensive chemotherapy, and posaconazole is...
7.
Lima K, Pereira-Martins D, de Miranda L, Coelho-Silva J, da Silva Leandro G, Weinhauser I, et al.
Blood Cancer J
. 2022 Nov;
12(11):151.
PMID: 36347832
The treatment of acute leukemia is challenging because of the genetic heterogeneity between and within patients. Leukemic stem cells (LSCs) are relatively drug-resistant and frequently relapse. Their plasticity and capacity...
8.
Mendes F, Silva W, Melo R, Silveira D, Velloso E, Rocha V, et al.
Ann Hematol
. 2021 Oct;
101(1):147-154.
PMID: 34676435
Despite advances in supportive measures, acute myeloid leukemia (AML) remission induction still has a high mortality rate in real-world studies as compared to prospective reports. We analyzed data from 206...
9.
Silva W, Rosa L, Seguro F, Silveira D, Bendit I, Buccheri V, et al.
Clinics (Sao Paulo)
. 2020 Apr;
75:e1566.
PMID: 32294670
Objectives: The outcomes of refractory and relapsed acute myeloid leukemia (AML) patients in developing countries are underreported, even though the similar classic regimens are widely used. Methods: We conducted a...
10.
Seguro F, Teixeira L, Rosa L, Silva W, Nardinelli L, Bendit I, et al.
J Thromb Thrombolysis
. 2020 Jan;
49(4):667-672.
PMID: 31898273
Few data are available regarding epidemiology and outcomes of Philadelphia-negative chronic myeloproliferative neoplasms (MPN) in Latin America. Therefore, current models for MPN treatment are based in large cohorts of patients...